PAKOXY 9MCY26 profit shoots 70%

October 27, 2026 (MLN): Pakistan Oxygen Limited (PSX: PAKOXY) reported a 70% surge in its net profit for the nine months ended September 30, 2026 (9MCY26), reaching Rs2.56bn compared to Rs1.51bn in the corresponding period last year.

Reflecting this solid bottom-line growth, basic and diluted earnings per share (EPS) expanded to Rs29.37, up from Rs17.32 in 9MCY25.

The primary catalyst driving the performance was a 21% expansion in net sales alongside a 38% growth in gross profit and a 51% reduction in finance costs.

Gross sales rose 21% to Rs13.20bn (up from Rs10.92bn in 9MCY25). After sales tax deductions of Rs1.74bn, net sales stood at Rs11.45bn compared to Rs9.47bn.

With cost of sales increasing modestly by 10% to Rs6.32bn, gross profit jumped to Rs5.13bn, up from Rs3.71bn in 9MCY25.

On the operational side, operating overheads expanded to support increased production scale and distribution footprint.

Distribution and marketing expenses rose 80% to Rs515.32m, administrative expenses increased 23% to Rs385.30m, and other operating expenses rose 53% to Rs332.16m.

Operating performance was further bolstered by an explosive surge in "other income" (Rs255.44m up from Rs33.20m), pushing operating profit up 42% to Rs4.15bn.

Below the operating line, PAKOXY gained substantial debt-servicing relief as finance costs were cut by more than half, falling 51% to Rs192.66m (down from Rs394.76m in 9MCY25).

With no minimum tax differential levy incurred during the period, profit before taxation rose 60% to Rs3.96bn.

The company recorded a corporate taxation charge of Rs1.40bn for the period (up 44% from Rs971.42m in 9MCY25).

Backed by strong industrial and medical gas demand, gross margin expansion, substantial deleveraging savings, and higher treasury income, Pakistan Oxygen Limited securely closed the nine-month period with its net profit reaching Rs2.56bn.

Copyright Mettis Link News